Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

PURPOSE: Adoptively transferred, ex vivo expanded multi-antigen-targeted T cells (multiTAA-T) represent a new, potentially effective, and nontoxic therapeutic approach for patients with breast cancer (BC). In this first-in-human trial, we investigated the safety and clinical effects of administering...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoyos, Valentina, Vasileiou, Spyridoula, Kuvalekar, Manik, Watanabe, Ayumi, Tzannou, Ifigeneia, Velazquez, Yovana, French-Kim, Matthew, Leung, Wingchi, Lulla, Suhasini, Robertson, Catherine, Foreman, Claudette, Wang, Tao, Bulsara, Shaun, Lapteva, Natalia, Grilley, Bambi, Ellis, Matthew, Osborne, Charles Kent, Coscio, Angela, Nangia, Julie, Heslop, Helen E., Rooney, Cliona M., Vera, Juan F., Lulla, Premal, Rimawi, Mothaffar, Leen, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161/
https://www.ncbi.nlm.nih.gov/pubmed/35860837
http://dx.doi.org/10.1177/17588359221107113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161/
https://www.ncbi.nlm.nih.gov/pubmed/35860837
http://dx.doi.org/10.1177/17588359221107113

Ejemplares similares